Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07190963 · ClinicalTrials.gov registry record
MindRhythm Detection of Concussion and Recovery Study
A clinical trial of mTBI - Mild Traumatic Brain Injury, sponsored by MindRhythm.
- Recruiting
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT07190963: Recruiting study of mTBI - Mild Traumatic Brain Injury, sponsored by MindRhythm.
NCT07190963 is a study of mTBI - Mild Traumatic Brain Injury that is actively recruiting participants, run by MindRhythm. The registered enrollment target is 150 participants, below the 206-participant average among 6 other mTBI - Mild Traumatic Brain Injury trials with a reported enrollment target (27% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07190963, a study of mTBI - Mild Traumatic Brain Injury, is actively recruiting participants, sponsored by MindRhythm.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is designed to observe HeadPulse data in concussed subjects that may have experienced a concussion via an injury down to the age of 4. Sports teams are the focus of this study because therein lies inherent potential risk for concussion. This observational study will further confirm the data previously collected in professional athletes to further validate that the HeadPulse can be used as a digital biometric to objectively indicate when a concussed brain remains concussed despite a subject feeling no symptoms has extreme value. This study is intended to support the development of a device to objectively determine when it is safe to return to play or normal activity based on the output of the digital biometric.
Conditions Studied
Study Locations (2)
California
- MindRhythm Incorporated - Cupertino
- MindRhythm Incorporated - Cupertino
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-01-28 |
| Est. Completion | 2027-03-30 |
What NCT07190963 shows while recruiting
NCT07190963 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 206-participant average among 6 other mTBI - Mild Traumatic Brain Injury trials with a reported enrollment target (27% lower).
The record links to 1 condition, with mTBI - Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.
NCT07190963 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07190963 about?
NCT07190963 is a clinical study titled "MindRhythm Detection of Concussion and Recovery Study". This study is designed to observe HeadPulse data in concussed subjects that may have experienced a concussion via an injury down to the age of 4. Sports teams are the focus of this study because therein lies inherent potential risk for concussion. This observational study will further confirm the da...
What is the current status of trial NCT07190963?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-01-28. Estimated completion is 2027-03-30.
What conditions does trial NCT07190963 study?
This clinical trial studies the following conditions: mTBI - Mild Traumatic Brain Injury.
Who is sponsoring clinical trial NCT07190963?
This trial is sponsored by MindRhythm, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07190963 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for mTBI - Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
RECRUITING
-
Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury
ACTIVE NOT RECRUITING · NA
-
Follow-up of MTBI Patients Discharged from the ED Using Standard Clinical Triage Including BrainScope One
ACTIVE NOT RECRUITING
-
Evaluation of Helmet Technology and Head Impact Exposure
COMPLETED · NA
-
Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology
COMPLETED · NA
-
Live Video Mind-body Treatment to Prevent Persistent Symptoms Following mTBI
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI